PD-L1 expression on tumor cells as a potential predictive biomarker for patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy followed by durvalumab

Detalles Bibliográficos
Autores principales: Käsmann, Lukas, Nieto, Alexander, Taugner, Julian, Manapov, Farkhad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175003/
https://www.ncbi.nlm.nih.gov/pubmed/37180646
http://dx.doi.org/10.21037/tcr-23-52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175003/
https://www.ncbi.nlm.nih.gov/pubmed/37180646
http://dx.doi.org/10.21037/tcr-23-52

Ejemplares similares